The Company is a premier walk-in medical care office offering an affordable alternative to the traditional urgent care model. In 2024, revenue was derived from: walk-in medical services (65%), allergy services (20%), and lab testing (15%). The Company accepts most commercial insurance plans, as well as out-of-pocket payments. Management estimates an approximately 80% rate of repeat patients.
INVESTMENT APPEAL
• Diversified Customer Base: No single customer accounted for more than 1% of revenue during the historical period. The diversified customer base helps ensure that the Company will not be significantly impacted by the loss of a single account.
• Outstanding Growth Opportunities: Several opportunities exist for the Company to significantly increase revenue and profit, including leveraging the Company’s proven reputation to pursue and penetrate new and existing markets, like weight management services.
• Recession-Resistant Industry: The Company operates in the healthcare industry, which is inherently recession-resistant due to the consistent demand for medical services, regardless of economic conditions.
• Modest Ongoing Capital Investment Requirements: Management does not expect a significant investment in capital assets to be required over the pro forma period.
